ono-4538
Showing 1 - 9 of 9
Advanced or Metastatic Solid Tumors Trial in Tokyo (ONO-4578, ONO-4538)
Active, not recruiting
- Advanced or Metastatic Solid Tumors
- ONO-4578
- ONO-4538
-
Nagoya, Aichi, Japan
- +21 more
Dec 13, 2022
Advanced NSCLC Trial in Taichung, Tainan, Taipei (ONO-4538)
Completed
- Advanced Non-small Cell Lung Cancer
- ONO-4538
-
Taichung, Taiwan
- +7 more
Apr 19, 2022
Pan-tumor Trial in Japan, Korea, Republic of, Taiwan (ONO-4538, oxaliplatin, S-1)
Recruiting
- Pan-tumor
- ONO-4538
- +3 more
-
Matsuyama, Ehime, Japan
- +21 more
Feb 27, 2022
Advanced Solid Tumors, Recurrent Solid Tumors Trial in Seongnam-si, Seoul (ONO-4538)
Completed
- Advanced Solid Tumors
- Recurrent Solid Tumors
- ONO-4538
-
Seongnam-si, Gyeonggi-do, Korea, Republic of
- +4 more
Nov 16, 2021
Advanced Solid Tumors, Recurrent Solid Tumors Trial in Seongnam-si, Seoul (ONO-4538)
Completed
- Advanced Solid Tumors
- Recurrent Solid Tumors
- ONO-4538
-
Seongnam-si, Gyeonggi-do, Korea, Republic of
- +4 more
Mar 19, 2021
Advanced NSCLC Trial in Korea, Republic of (ONO-4538)
Completed
- Advanced Non-small Cell Lung Cancer
- ONO-4538
-
Cheongju-si, Chungcheongbuk-do, Korea, Republic of
- +9 more
Mar 19, 2021
Gastric Cancer Trial in Japan, Korea, Republic of, Taiwan (ONO-4538, Placebo)
Completed
- Gastric Cancer
- ONO-4538
- Placebo
-
Nagoya, Aichi, Japan
- +48 more
Nov 16, 2021
Gastric Cancer Trial in Japan, Korea, Republic of, Taiwan (ONO-4538, Ipilimumab, Oxaliplatin)
Recruiting
- Gastric Cancer
- ONO-4538
- +4 more
-
Kashiwa-shi, Chiba, Japan
- +56 more
Jun 1, 2022
Gastric Cancer Trial in Japan, Korea, Republic of, Taiwan (ONO-4538, Oxaliplatin, Tegafur- Gimeracil-Oteracil potassium)
Active, not recruiting
- Gastric Cancer
- ONO-4538
- +4 more
-
Nagoya, Aichi, Japan
- +129 more
Apr 20, 2022